NBIX vs WST · P/E 45, rev $1.77B vs P/E 35, rev $1.72B
Neurocrine Biosciences Inc (NBIX) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the NBIX and WST stock pages for the full models.
Not investment advice.